Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients?

被引：0
作者：
Marc D. Moncrieff
Richard Martin
Christopher J. O’Brien
Kerwin F. Shannon
Jonathan R. Clark
Kan Gao
William M. McCarthy
John F. Thompson
机构：
[1] Royal Prince Alfred Hospital,The Sydney Melanoma Unit
[2] Royal Prince Alfred Hospital,The Sydney Head and Neck Cancer Institute
[3] The University of Sydney,The Discipline of Surgery
[4] Royal Prince Alfred Hospital,The Sydney Cancer Centre
来源：
Annals of Surgical Oncology | 2008年 / 15卷
关键词：
Melanoma; Sentinel Lymph Node Biopsy; Neck Dissection; Adjuvant Radiotherapy; Regional Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3022 / 3027
页数：5
相关论文
共 50 条
[31]   Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma [J].
Jonasch, E ;
Kumar, UN ;
Linette, GP ;
Hodi, FS ;
Soiffer, RJ ;
Ryan, BF ;
Sober, AJ ;
Mihm, MC ;
Tsao, H ;
Langley, RG ;
Cosimi, BA ;
Gadd, MA ;
Tanabe, KK ;
Souba, W ;
Haynes, HA ;
Barnhill, R ;
Osteen, R ;
Haluska, FG .
CANCER JOURNAL, 2000, 6 (03) :139-145
[32]   Feasibility of high-dose interferon-α2b adjuvant therapy for high-risk resected cutaneous melanoma [J].
Muggiano, A ;
Mulas, C ;
Fiori, B ;
Liciardi, G ;
Pintus, M ;
Tanca, L ;
Tedde, A ;
Turno, R ;
Desogus, A .
MELANOMA RESEARCH, 2004, 14 (02) :S1-S7
[33]   High frequency of brain metastases after adjuvant therapy for high-risk melanoma [J].
Samlowski, Wolfram E. ;
Moon, James ;
Witter, Merle ;
Atkins, Michael B. ;
Kirkwood, John M. ;
Othus, Megan ;
Ribas, Antoni ;
Sondak, Vernon K. ;
Flaherty, Lawrence E. .
CANCER MEDICINE, 2017, 6 (11) :2576-2585
[34]   Influence of Adjuvant Radiotherapy Timing on Survival Outcomes in High-Risk Patients Receiving Neoadjuvant Treatments [J].
Cao, Lu ;
Xu, Cheng ;
Wang, Meng-Di ;
Qi, Wei-Xiang ;
Cai, Gang ;
Cai, Rong ;
Wang, Shu-Bei ;
Ou, Dan ;
Li, Min ;
Shen, Kun-Wei ;
Chen, Jia-Yi .
FRONTIERS IN ONCOLOGY, 2022, 12
[35]   Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit?: A meta-analysis of the randomised trials [J].
Wheatley, K ;
Ives, N ;
Hancock, B ;
Gore, M ;
Eggermont, A ;
Suciu, S .
CANCER TREATMENT REVIEWS, 2003, 29 (04) :241-252
[36]   Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain [J].
González-Larriba, JL ;
Serrano, S ;
Alvarez-Mon, M ;
Camacho, F ;
Casado, MA ;
Díaz-Pérez, JL ;
Díaz-Rubio, E ;
Fosbrook, L ;
Guillem, V ;
López-López, JJ ;
Moreno-Nogueira, JA ;
Toribio, J .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) :2344-2352
[37]   Adjuvant strategies for high-risk melanoma [Adjuvante strategien bei hochrisikomelanomen] [J].
Fluck M. ;
Garbe C. .
Der Onkologe, 2014, 20 (6) :555-567
[38]   Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival [J].
Casas, F. ;
Valduvieco, I. ;
Oses, G. ;
Izquierdo, L. ;
Archila, I. ;
Costa, M. ;
Cortes, K. S. ;
Barreto, T. ;
Ferrer, F. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03) :355-362
[39]   ROLE OF POSTOPERATIVE IRRADIATION FOR PATIENTS WITH BILATERAL CERVICAL NODAL METASTASES FROM CUTANEOUS MELANOMA: A CRITICAL ASSESSMENT [J].
Guadagnolo, B. Ashleigh ;
Myers, Jeffrey N. ;
Zagars, Gunar K. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (06) :708-713
[40]   Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival [J].
F. Casas ;
I. Valduvieco ;
G. Oses ;
L. Izquierdo ;
I. Archila ;
M. Costa ;
K. S. Cortes ;
T. Barreto ;
F. Ferrer .
Clinical and Translational Oncology, 2019, 21 :355-362
12345